Novozymes Operating Income 2011-2023 | NVZMY

Novozymes operating income for the twelve months ending December 31, 2023 was $0.577B, a 10.61% decline year-over-year.

  • Novozymes annual operating income for 2023 was $0.577B, a 10.61% decline from 2022.
  • Novozymes annual operating income for 2022 was $0.646B, a 1.31% increase from 2021.
  • Novozymes annual operating income for 2021 was $0.638B, a 13.95% increase from 2020.

Novozymes Operating Income 2011-2023 | NVZMY

  • Novozymes annual operating income for 2023 was $0.577B, a 10.61% decline from 2022.
  • Novozymes annual operating income for 2022 was $0.646B, a 1.31% increase from 2021.
  • Novozymes annual operating income for 2021 was $0.638B, a 13.95% increase from 2020.
Related Stocks
Company NameMarket
Cap
Linde (LIN)$221.6B
Sherwin-Williams (SHW)$96.7B
Ecolab (ECL)$69.7B
PPG Industries (PPG)$29.2B
International Flavors & Fragrances (IFF)$23.3B
Celanese (CE)$9.8B
Axalta Coating Systems (AXTA)$8.7B
CSW Industrials (CSWI)$7B
Element Solutions (ESI)$7B
Arcadium Lithium (ALTM)$5.8B
Balchem (BCPC)$5.7B
Valvoline (VVV)$5.6B
NewMarket (NEU)$5.4B
Nissan Chemical (NNCHY)$4.4B
H B Fuller (FUL)$4.3B
Ashland (ASH)$3.9B
Sensient Technologies (SXT)$3.4B
Quaker Houghton (KWR)$3B
Minerals Technologies (MTX)$2.6B
Hawkins (HWKN)$2.5B
Perimeter Solutions, SA (PRM)$2B
Orbia Advance, S.A.B De C.V (MXCHY)$1.8B
Ingevity (NGVT)$1.7B
DAQO New Energy (DQ)$1.5B
ELEMENTIS (ELMTY)$1.3B
Orion S.A (OEC)$959M
Huabao Holdings (HUIHY)$943M
AdvanSix (ASIX)$832M
Westlake Chemical Partners LP (WLKP)$793M
Green Plains (GPRE)$758M